The company expired its plan on December 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.55 CNY | -1.49% | -3.54% | -14.56% |
May. 31 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024 | CI |
May. 06 | China Approves Tianyu Pharma's Heart Medication | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.56% | 892M | |
+20.76% | 43.54B | |
+18.60% | 21.51B | |
+19.07% | 15.34B | |
+26.36% | 15.12B | |
+56.55% | 13.37B | |
-0.05% | 6.79B | |
-15.94% | 6.38B | |
-8.87% | 5.73B | |
+16.15% | 5.36B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 30, 2022, has expired with 2,403,643 shares, representing 0.69% for CNY 58 million.